Log In
Print this Print this


Also known as: Claudiximab

  Manage Alerts
Collapse Summary General Information
Company Ganymed Pharmaceuticals AG
Description mAb targeting cell surface antigen CLND18.2
Molecular Target CLND18.2
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today